# Vinorelbine

NDC: 25021-204
Generic name: Vinorelbine
Labeler / Manufacturer: Sagent Pharmaceuticals
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20140915

FDA application: ANDA091106

## Active ingredients

- VINORELBINE TARTRATE: 10 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"25021-204"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=25021-204
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=10a70995-e04d-4044-b1dc-c9aa27460397
